Company Registration No. 13694696 (England and Wales)
NOVEL SWAN PHARMA LIMITED
Unaudited accounts
for the year ended 31 October 2023
NOVEL SWAN PHARMA LIMITED
Unaudited accounts
Contents
NOVEL SWAN PHARMA LIMITED
Company Information
for the year ended 31 October 2023
Directors
Mr. Chun Hin Wong
Mr. Yuen Fung Lam
Mr. Him Shuen Chung
Dr. Philip Majoe
Company Number
13694696 (England and Wales)
Registered Office
178 CAERAU ROAD
MAESTEG
CF34 0PD
WALES
Accountants
Kimee & Associates
Office T, First Floor, Raydean House,
15-17 Western Parade, Great North Road
Barnet, London
EN5 1AH
NOVEL SWAN PHARMA LIMITED
Statement of financial position
as at 31 October 2023
Intangible assets
1,148,000
1,209,500
Tangible assets
100,000
100,000
Cash at bank and in hand
36,339
-
Creditors: amounts falling due within one year
(1,500)
-
Net current assets
34,839
140,000
Total assets less current liabilities
1,282,839
1,449,500
Creditors: amounts falling due after more than one year
(1,337,118)
(1,466,045)
Net liabilities
(54,279)
(16,545)
Called up share capital
100
100
Profit and loss account
(54,379)
(16,645)
Shareholders' funds
(54,279)
(16,545)
For the year ending 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 17 April 2024 and were signed on its behalf by
Mr. Him Shuen Chung
Director
Company Registration No. 13694696
NOVEL SWAN PHARMA LIMITED
Notes to the Accounts
for the year ended 31 October 2023
NOVEL SWAN PHARMA LIMITED is a private company, limited by shares, registered in England and Wales, registration number 13694696. The registered office is 178 CAERAU ROAD, MAESTEG, CF34 0PD, WALES.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
4
Intangible fixed assets
Goodwill
At 1 November 2022
1,230,000
At 31 October 2023
1,230,000
Charge for the year
61,500
At 31 October 2023
1,148,000
At 31 October 2022
1,209,500
NOVEL SWAN PHARMA LIMITED
Notes to the Accounts
for the year ended 31 October 2023
5
Tangible fixed assets
Land & buildings
At 1 November 2022
100,000
At 31 October 2023
100,000
At 31 October 2023
100,000
At 31 October 2022
100,000
Amounts falling due within one year
7
Creditors: amounts falling due within one year
2023
2022
8
Creditors: amounts falling due after more than one year
2023
2022
Bank loans
1,285,502
1,341,329
Loans from directors
51,616
124,716
Directors's Loan £124,716
Barclays Business Loan £1,341,329
9
Average number of employees
During the year the average number of employees was 0 (2022: 0).